ICICI Prudential Nifty Pharma Index Fund - Growth vs Kotak Nifty SDL Apr 2027 Top 12 Equal Weight Index Fund-Direct Plan-Growth

Side-by-side comparison of NAV, returns, expense ratio and star rating.

TopFund Analysis

Kotak Nifty SDL Apr 2027 Top 12 Equal Weight Index Fund-Direct Plan-Growth appears stronger based on its higher star rating of 5 compared to ICICI Prudential Nifty Pharma Index Fund - Growth's rating of 2, indicating better overall performance and management. However, investors should note the tradeoff: while Kotak has a significantly lower expense ratio of 0.2012%, it also offers lower returns over the 1-year and 3-year periods compared to ICICI Prudential, which boasts returns of 24.16% and 20.83% respectively. For investors choosing between these funds, the decision may hinge on whether they prioritize higher returns or a more favorable rating and lower costs.

ICICI Prudential Mutual Fund

ICICI Prudential Nifty Pharma Index Fund - Growth

ICICI Prudential Mutual Fund

★★★★★

Other · Index Funds

Kotak Mahindra Mutual Fund

Kotak Nifty SDL Apr 2027 Top 12 Equal Weight Index Fund-Direct Plan-Growth

Kotak Mahindra Mutual Fund

★★★★★

Other · Index Funds

Metric ICICI Prudential Nifty... Kotak Nifty SDL Apr 20...
NAV ₹21.42 ₹13.39
Star Rating ★★ ★★★★★
Expense Ratio 0.51% 0.2012%
AUM ₹163 Cr ₹6,136 Cr
1M Return +10.68% +0.62%
3M Return +7.56% +1.28%
6M Return +13.89% +2.88%
1Y Return +24.16% +5.84%
3Y CAGR +20.83% +7.48%
Risk Level — —
Fund Manager Nishit Patel Abhishek Bisen